BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17477132)

  • 21. SERRS immunoassay for quantitative human CRP analysis.
    Campbell FM; Ingram A; Monaghan P; Cooper J; Sattar N; Eckersall PD; Graham D
    Analyst; 2008 Oct; 133(10):1355-7. PubMed ID: 18810282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High C-reactive protein and low cholesterol levels are prognostic markers of survival in severe sepsis.
    Memiş D; Gursoy O; Tasdogan M; Süt N; Kurt I; Türe M; Karamanlioğlu B
    J Clin Anesth; 2007 May; 19(3):186-91. PubMed ID: 17531726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetically elevated C-reactive protein and vascular disease.
    Morita H; Nagai R
    N Engl J Med; 2009 Feb; 360(9):934; author reply 934-5. PubMed ID: 19256031
    [No Abstract]   [Full Text] [Related]  

  • 24. On call. I've been hearing a lot about C-reactive protein and heart attacks. I want to stay healthy, but I'm 73 years old, and there seems to be a new worry in every newspaper I read. At my age, does this protein make any difference?
    Simon HB
    Harv Mens Health Watch; 2007 Nov; 12(4):8. PubMed ID: 18217257
    [No Abstract]   [Full Text] [Related]  

  • 25. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk.
    Hage FG; Szalai AJ
    J Am Coll Cardiol; 2007 Sep; 50(12):1115-22. PubMed ID: 17868801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].
    Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG
    Ugeskr Laeger; 2009 May; 171(21):1751-5. PubMed ID: 19492468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-sensitivity C-reactive protein in every chart? The use of biomarkers in individual patients.
    Ben-Yehuda O
    J Am Coll Cardiol; 2007 May; 49(21):2139-41. PubMed ID: 17531664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New tool refines heart risk prediction. Adding C-reactive protein and family history modernizes and improves the standard risk tool.
    Harv Heart Lett; 2007 May; 17(9):4-5. PubMed ID: 17517984
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple biomarkers and cardiovascular risk.
    Austin MJ; Heneghan MA
    N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791
    [No Abstract]   [Full Text] [Related]  

  • 30. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter by Ridker and Everett regarding article, "The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?".
    Ridker PM; Everett BM
    Circulation; 2007 May; 115(20):e475; author reply e476. PubMed ID: 17515471
    [No Abstract]   [Full Text] [Related]  

  • 32. Delirium and C-reactive protein.
    George J; Mukaetova-Ladinska EB
    Age Ageing; 2007 Mar; 36(2):115-6. PubMed ID: 17189284
    [No Abstract]   [Full Text] [Related]  

  • 33. Endogenous sex hormones and C-reactive protein in healthy postmenopausal women.
    Störk S; Bots ML; Grobbee DE; van der Schouw YT
    J Intern Med; 2008 Sep; 264(3):245-53. PubMed ID: 18341528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population.
    Muscari A; Antonelli S; Bianchi G; Cavrini G; Dapporto S; Ligabue A; Ludovico C; Magalotti D; Poggiopollini G; Zoli M;
    Diabetes Care; 2007 Sep; 30(9):2362-8. PubMed ID: 17595349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein and blood pressure in infants.
    Trevisanuto D; Avezzù F; Mario F; Doglioni N; Zanardo V
    J Pediatr; 2008 Apr; 152(4):596. PubMed ID: 18346526
    [No Abstract]   [Full Text] [Related]  

  • 36. Is waist circumference an essential component of the metabolic syndrome?
    Lorenzo C; Serrano-Ríos M; Martínez-Larrad MT; González-Villalpando C; González-Sánchez JL; Martínez-Calatrava MJ; Gabriel R; Haffner SM
    Diabetes Care; 2007 Aug; 30(8):2141-2. PubMed ID: 17519434
    [No Abstract]   [Full Text] [Related]  

  • 37. [Periodic fever in small children].
    Holt J
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1664. PubMed ID: 17615624
    [No Abstract]   [Full Text] [Related]  

  • 38. Is C-reactive protein a biomarker for immediate clinical outcome after cardiac surgery?
    Corral L; Carrió ML; Ventura JL; Torrado H; Javierre C; Rodriguez-Castro D; Farrero E; Valero J; Ortiz D
    J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):166-9. PubMed ID: 19201207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
    Rajagopalan S; Zannad F; Radauceanu A; Glazer R; Jia Y; Prescott MF; Kariisa M; Pitt B
    Am J Cardiol; 2007 Jul; 100(2):222-6. PubMed ID: 17631074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mean peroxidase index as a potential marker for neonatal infection.
    Song KS
    Pediatr Infect Dis J; 2006 Dec; 25(12):1194. PubMed ID: 17133174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.